Vertex Pharmaceuticals Inc
VRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000875320
In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 1,770 institutions reported holding it in 13F filings for Q2 2026, worth $119.7B in total; no superinvestor holds it.
Holders of 5% or more of VRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vertex Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 10.10%25.7M shares | −1.10 ppfrom 11.20% | Feb 13, 20235 filings | May 14, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 7.49%19.0M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
| Capital Research Global Investors | 13G/A | 7.00%17.8M shares | −1.30 ppfrom 8.30% | May 13, 20254 filings | Nov 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
26 Schedule 13D and 13G filings on Vertex Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 20265:08 PM ET | Capital Research Global Investors | 13G/A | 7.00%17.8M shares | −1.30 ppfrom 8.30% | Sep 30, 2026 | SEC |
| May 14, 20261:55 PM ET | Capital World Investors | 13G/A | 10.10%25.7M shares | −1.10 ppfrom 11.20% | Mar 31, 2026 | SEC |
| May 14, 202610:19 AM ET | Capital Research Global Investors | 13G/A | 8.30%21.1M shares | +1.50 ppfrom 6.80% | Mar 31, 2026 | SEC |
| Apr 30, 20262:29 PM ET | Vanguard Capital Management LLC | 13G | 7.49%19.0M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 20261:54 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 12, 202610:25 AM ET | Capital Research Global Investors | 13G/A | 6.80%17.3M shares | +1.10 ppfrom 5.70% | Dec 31, 2025 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G | 5.70%14.5M shares | New | Mar 31, 2025 | SEC |
| Feb 13, 20254:53 PM ET | Capital World Investors | 13G/A | 11.20%28.7M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:34 AM ET | FMR LLCand 1 other | 13G/A | 3.60%9.22M shares | –Below 5% | Dec 31, 2024 | SEC |
| Apr 10, 2024 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Capital World Investors | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20241:48 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital World Investors | 13GOld format | – | New | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13GOld format | – | – | – | SEC |
| Jan 24, 20231:56 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20218:23 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
190 notices from officers, directors and other affiliates planning to sell Vertex Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 202610:23 AM ET | Wagner Charles F JrOfficer | 15.3K | $8.37M | Nov 12, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Nov 6, 202610:29 AM ET | Kewalramani ReshmaOfficer · Director | 11.9K | $6.31M | Nov 6, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Aug 27, 20264:46 PM ET | Bruce I. SachsDirector | 1.21K | $662.5K | Aug 27, 2026 | Goldman Sachs & Co. LLC | SEC |
| Jul 2, 20264:30 PM ET | Tatsis OuraniaOfficer | 1.50K | $787.5K | Jul 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jul 2, 20262:16 PM ET | McKechnie DuncanOfficer | 1.54K | $799.8K | Jul 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jul 1, 20261:00 PM ET | Liu JoyOfficer | 828 | $416.2K | Jul 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 26, 20269:54 AM ET | Bozic CarmenOfficer | 596 | $287.6K | Jun 26, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 18, 202611:33 AM ET | Bozic CarmenOfficer | 1.02K | $471.4K | Jun 18, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 15, 20263:07 PM ET | Bozic CarmenOfficer | 4.06K | $1.83M | Jun 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 5, 20262:33 PM ET | Bozic CarmenOfficer | 1.75K | $785.3K | Jun 5, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 1, 20262:13 PM ET | Liu JoyOfficer | 828 | $364.2K | Jun 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 29, 20261:31 PM ET | Bozic CarmenOfficer | 1.97K | $888.3K | May 29, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 15, 202610:41 AM ET | Bozic CarmenOfficer | 1.35K | $614.0K | May 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 15, 202610:02 AM ET | Bunnage Mark E.Officer | 33 | $15.0K | May 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 12, 20261:11 PM ET | Bozic CarmenOfficer | 6.99K | $3.14M | May 12, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 6, 20262:13 PM ET | Biller JonathanOfficer | 5.19K | $2.20M | May 6, 2026 | Fidelity Brokerage Services LLC | SEC |
| May 4, 202610:18 AM ET | Bhatia Sangeeta N.Director | 318 | $134.7K | May 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 1, 20262:28 PM ET | Liu JoyOfficer | 1.10K | $469.2K | May 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Apr 1, 20261:02 PM ET | Liu JoyOfficer | 978 | $439.3K | Apr 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 27, 202610:32 AM ET | Bozic CarmenOfficer | 2.33K | $1.05M | Mar 27, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 13, 202611:38 AM ET | Bozic CarmenOfficer | 2.33K | $1.12M | Mar 13, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 11, 20269:44 AM ET | McKechnie DuncanOfficer | 2.63K | $1.31M | Mar 11, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 4, 202610:09 AM ET | McKechnie DuncanOfficer | 2.44K | $1.16M | Mar 4, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Mar 2, 20265:09 PM ET | Liu JoyOfficer | 892 | $442.4K | Mar 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Feb 27, 20264:41 PM ET | Kewalramani ReshmaOfficer · Director | 40.0K | $19.7M | Feb 27, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
Showing the latest 25. See the VRTX notices from the last 12 months